Recent advances in the understanding of tau protein and movement disorders

Current Opinion in Neurology

Volumn 14, Issue 4, 2001, Pages 491-497

  Arvanitakis, Zoe ^a   Wszolek, Zbigniew K ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TAU PROTEIN;

ALTERNATIVE RNA SPLICING; ANIMAL MODEL; CHROMOSOME 17; CLINICAL FEATURE; CORTICOBASAL DEGENERATION; FRONTOTEMPORAL DEMENTIA; GENE MUTATION; MOLECULAR GENETICS; MOTOR DYSFUNCTION; PARKINSONISM; PICK PRESENILE DEMENTIA; POSITRON EMISSION TOMOGRAPHY; PROGRESSIVE SUPRANUCLEAR PALSY; REVIEW;

ATROPHY; BRAIN; CEREBRAL CORTEX; DEMENTIA; DIAGNOSIS, DIFFERENTIAL; HUMANS; NEURODEGENERATIVE DISEASES; NEUROMUSCULAR DISEASES; PARKINSON DISEASE; SUPRANUCLEAR PALSY, PROGRESSIVE; TAU PROTEINS;

EID: 0034904509     PISSN: 13507540     EISSN: None     Source Type: Journal    
DOI: 10.1097/00019052-200108000-00010     Document Type: Review

References (36)

1. Frontotemporal dementia and parkinsonism linked to chromosome 17: A consensus conference. Conference Participants
2. Localization of disinhibition-dementia-parkinsonism-amyotrophy complex to 17q21-22
3. Association of missense and 5′-splice-site mutations in tau with the inherited dementia FTDP-17
4. Tau protein pathology in neurodegenerative diseases
5. Phenotypic correlations in FTDP-17
6. A mutation in the microtubule-associated protein tau in pallido-nigro-luysian degeneration
7. Familial frontotemporal dementia with a P301L tau mutation in Japan
8. Progressive supranuclear palsy pathology caused by a novel silent mutation in exon 10 of the tau gene, expansion of the disease phenotype caused by tau gene mutations
9. Two brothers with frontotemporal dementia and parkinsonism with an N279K mutation of the tau gene
10. Two brothers with frontotemporal dementia and parkinsonism with an N279K mutation of the tau gene
11. Positron emission tomography in pallido-ponta-nigral degeneration (PPND) family (frontotemporal dementia with parkinsonism linked to chromosome 17 and point mutation in tau gene)
12. The molecular genetics of the tauopathies
13. A mutation in the microtubule-associated protein tau in pallido-nigro-luysian degeneration
14. A novel tau mutation (N296N) in familial dementia with swollen achromatic neurons and corticobasal inclusion bodies
15. A novel mutation at position + 12 in the intron following exon 10 of the tau gene in familial frontotemporal dementia (FTD-Kumamoto)
16. Frontotemporal dementia with novel tau pathology and a Glu342Val tau mutation
17. The neuropathology of a chromosome 17-linked autosomal dominant parkinsonism and dementia ('pallido-ponto-nigral degeneration')
18. Pick's disease is associated with mutations in the tau gene
19. Research goals in progressive supranuclear palsy. First International Brainstorming Conference on PSP
20. Application of the Unified Parkinson's Disease Rating Scale in progressive supranuclear palsy: Factor analysis of the motor scale
21. Longitudinal ocular motor study in corticobasal degeneration and progressive supranuclear palsy
22. Neuropsychological follow up in patients with Parkinson's disease, striatonigral degeneration-type multisystem atrophy, and progressive supranuclear palsy
23. Smoking habits in multiple system atrophy and progressive supranuclear patsy
24. Physiological, pharmacological and neurohormonal assessment of autonomic function in progressive supranuclear palsy
25. Progressive supranuclear palsy: Earlier age of onset in patients with the tau protein A0/A0 genotype
26. A role for the substantia nigra pars reticulata in the gaze palsy of progressive supranuclear palsy
27. Regional brain atrophy in progressive supranuclear palsy and Lewy body disease
28. Frontal lobe dysfunction in progressive supranuclear palsy: Evidence for oxidative stress and mitochondrial impairment
29. Clinical features differentiating patients with postmortem confirmed progressive supranuclear patsy and corticobasal degeneration
30. Neuropathologic differentiation of progressive supranuclear palsy and corticobasal degeneration
31. The corticobasal degeneration syndrome overlaps progressive aphasia and frontotemporal dementia
32. Features of regional cerebral glucose metabolism abnormality in corticobasal degeneration
33. Corticobasal degeneration shares a common genetic background with progressive supranuclear palsy
34. A quantitative study of the pathological lesions in the neocortex and hippocampus of twelve patients with corticobasal degeneration
35. Neurofibrillary tangles, amyotrophy and progressive motor disturbance in mice expressing mutant (P301L) tau protein
36. Characterization of pathology in transgenic mice over-expressing human genomic and cDNA tau transgenes